Dopamine agonists and neuroleptic malignant syndrome.
D000544:Alzheimer Disease / Q000188:drug therapy; D000547:Amantadine / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000209:etiology*; D001971:Bromocriptine / Q000627:therapeutic use; D003620:Dantrolene / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D001971:Bromocriptine; D000547:Amantadine; D003620:Dantrolene